Anastasios Maniakas

Assistant Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Anastasios Maniakas is an Assistant Professor at The University of Texas MD Anderson Cancer Center in the United States. His research primarily focuses on advanced thyroid cancers, including the use of biomarkers and novel therapeutic strategies. Recent articles authored by Dr. Maniakas delve into topics such as the management of anaplastic thyroid cancer and the efficacy of targeted therapies for hereditary medullary thyroid carcinoma.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Marie-Claude Hofmann

Professor

The University of Texas MD Anderson Cancer Center Children's Cancer Hospital

UNITED STATES

View details

Michelle D. Williams

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Renata Ferrarotto

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Stephen Lai

Professor (Dual/Adjunct)

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Miriam Lango

UNITED STATES

View details

Maria E. Cabnillas

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Akanksha Srivastava

Assistant Professor

University of Chicago

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anastasios Maniakas

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer

Characterization of Advanced RAS-driven Follicular-derived Thyroid Cancers and Review of Future Therapeutic Avenues

Circulating Tumor DNA as a Biomarker for Disease Surveillance in Anaplastic Thyroid Cancer

Partial Laryngectomy for Thyroid Cancer: A Single Institution Case Series With Operative Techniques

Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma

[18F]-Fluorodeoxyglucose Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma Following BRAF-Targeted Therapy.

Patterns of loco-regional progression and patient outcomes after definitive-dose radiation therapy for anaplastic thyroid cancer.

Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement.

Immune Checkpoint Inhibitor Therapy for Periocular Merkel Cell Carcinoma.

Reply to Letter to the Editor regarding “Decreased utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer”

Low-dose and long-term azithromycin significantly decreases Staphylococcus aureus in the microbiome of refractory CRS patients

Reconstruction of intraoral oncologic surgical defects with Integra<sup>®</sup> bilayer wound matrix

Subannular ventilation tubes in the pediatric population: Clinical outcomes of over 1000 insertions

Azithromycin downregulates gene expression of IL-1b and pathways involving TMPRSS2 and TMPRSS11D required by SARS-CoV-2

Azithromycin in high-risk, refractory chronic rhinosinusitus after endoscopic sinus surgery and corticosteroid irrigations: a double-blind, randomized, placebo-controlled trial

Evaluation of Overall Survival in Patients with Anaplastic Thyroid Carcinoma, 2000-2019

Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic

Risk for Thyroid Cancer Recurrence Is Higher in Men Than in Women Independent of Disease Stage at Presentation

Collaborators (7)

Marie-Claude Hofmann

Michelle D. Williams

Renata Ferrarotto

Stephen Lai

Miriam Lango

Maria E. Cabnillas

Akanksha Srivastava

Make your next move.